ArticlePDF Available

Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study

Authors:
  • CONCORDIA

Abstract

Background: Time restricted feeding decreases energy intake without calorie counting and may be a viable option for weight loss. However, the effect of this diet on body weight in obese subjects has never been examined. Objective: This study investigated the effects of 8-h time restricted feeding on body weight and metabolic disease risk factors in obese adults. Design: Obese subjects (n = 23) participated in an 8-h time restricted feeding intervention (ad libitum feeding between 10:00 to 18:00 h, water fasting between 18:00 to 10:00 h) for 12 weeks. Weight loss and other outcomes were compared to a matched historical control group (n = 23). Results: Body weight and energy intake decreased in the time restricted group (-2.6% ± 0.5; -341 ± 53 kcal/d) relative to controls over 12 weeks (P < 0.05). Systolic blood pressure decreased in the time restricted feeding group (-7 ± 2 mm Hg) versus controls (P < 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine were not significantly different from controls after 12 weeks (no group×time interaction). Conclusion: These findings suggest that 8-h time restricted feeding produces mild caloric restriction and weight loss, without calorie counting. It may also offer clinical benefits by reducing blood pressure.
Uncorrected Author Proof
Nutrition and Healthy Aging xx (20xx) x–xx
DOI 10.3233/NHA-170036
IOS Press
1
Effects of 8-hour time restricted feeding
on body weight and metabolic disease risk
factors in obese adults: A pilot study
1
2
3
Kelsey Gabela, Kristin K. Hoddya, Nicole Haggertya, Jeehee Songa, Cynthia M. Kroegera,b,
John F. Trepanowskia, Satchidananda Pandacand Krista A. Varadya,
4
5
aDepartment of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, USA6
bSchool of Public Health, Indiana University, Bloomington, IN, USA7
cRegulatory Biology Lab, Salk Institute for Biological Studies, La Jolla, CA, USA8
Abstract.9
BACKGROUND: Time restricted feeding decreases energy intake without calorie counting and may be a viable option for
weight loss. However, the effect of this diet on body weight in obese subjects has never been examined.
10
11
OBJECTIVE: This study investigated the effects of 8-h time restricted feeding on body weight and metabolic disease risk
factors in obese adults.
12
13
DESIGN: Obese subjects (n= 23) participated in an 8-h time restricted feeding intervention (ad libitum feeding between
10:00 to 18:00 h, water fasting between 18:00 to 10:00 h) for 12 weeks. Weight loss and other outcomes were compared to a
matched historical control group (n= 23).
14
15
16
RESULTS: Body weight and energy intake decreased in the time restricted group (–2.6% ±0.5; –341 ±53 kcal/d) relative
to controls over 12 weeks (P<0.05). Systolic blood pressure decreased in the time restricted feeding group (–7±2 mm Hg)
versus controls (P< 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol,
triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine were not significantly different from controls
after 12 weeks (no group ×time interaction).
17
18
19
20
21
CONCLUSIONS: These findings suggest that 8-h time restricted feeding produces mild caloric restriction and weight loss,
without calorie counting. It may also offer clinical benefits by reducing blood pressure.
22
23
Keywords: Time restricted feeding, intermittent fasting, body weight, metabolic disease risk factors, obese adults24
1. Introduction
25
Intermittent fasting has gained considerable pop-26
ularity over the past decade. There are two major
27
subcategories of intermittent fasting: 1) fasting 1–428
d per week, i.e. alternate day fasting or the 5:2 diet29
[1]; or 2) fasting every day for a 14 to 20h period, i.e.
30
time restricted feeding [2, 3]. Alternate day fasting31
and 5:2 are the most widely studied forms of inter-
32
Corresponding author: Krista A. Varady, PhD, Associate Pro-
fessor of Nutrition, Department of Kinesiology and Nutrition,
University of Illinois at Chicago, 1919 West Taylor Street, Room
532, Chicago, 60612, IL, USA. Tel.: +1 312 996 7897; E-mail:
varady@uic.edu.
mittent fasting [4–10]. Human trials of alternate day 33
fasting and 5:2 generally demonstrate reductions in 34
body weight of 3 to 8% after 8 to 52 weeks of treat- 35
ment, accompanied by decreases in blood pressure, 36
LDL cholesterol, triglycerides, and insulin resistance 37
[4–10]. The effects of time restricted feeding on the 38
other hand, have only been tested in three human tri- 39
als to date [11–13]. Gill and Panda [11] examined the 40
effects of 10-h time restricted feeding in overweight 41
healthy adults and showed a 4% weight loss that was 42
sustained for one year. Findings from the other two 43
studies [12, 13] reveal that 4–8 h time restricted feed- 44
ing reduces caloric intake (without calorie counting) 45
and significantly decreases fat mass without chang- 46
ISSN 2451-9480/18/$35.00 © 2018 – IOS Press and the authors. All rights reserved
This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC 4.0).
Uncorrected Author Proof
2K. Gabel et al. / Time restricted feeding for weight loss
ing lean mass in young resistance trained men. While47
these preliminary studies offer promise for the use of
48
time restricted feeding in reducing energy intake and49
fat mass, additional trials are necessary to confirm50
these findings.51
Obesity greatly increases the risk of metabolic
52
diseases, such a coronary heart disease and type 2 dia-53
betes [14]. Accumulating evidence suggests that even54
small amounts of weight loss can lead to improve-55
ments in metabolic health [15]. Although alternate
56
day fasting and 5:2 have been shown to be effec-57
tive for weight loss [4–9], recent research suggests58
that obese individuals may have difficulties sticking
59
to these diets long-term [10]. Time restricted feed-60
ing is an attractive alternative to alternate day fasting
61
and 5:2, as this diet allows for ad libitum feeding62
within a large window of time each day, and does not63
require any calorie counting [2, 3]. However, no trial
64
to date has examined whether time restricted feeding65
is indeed an effective diet therapy for weight loss and66
metabolic disease risk reduction in obese subjects.67
Accordingly, this study compared the effects of68
an 8-h time restricted feeding regimen versus a no-69
intervention historical control group on body weight70
and metabolic disease risk factors in obese adults.
71
We hypothesized that the time restricted feeding
72
group would lose weight and improve blood pressure,73
plasma lipids, and glucoregulatory factors versus
74
control subjects after 12 weeks of treatment.75
2. Methods76
2.1. Time restricted feeding subject selection77
A 12-week trial was implemented to test the effects78
of time restricted feeding versus matched histori-
79
cal controls on body weight and metabolic disease
80
risk factors. The experimental protocol was approved
81
by the University of Illinois Chicago Office for the
82
Protection of Research Subjects, and all research83
participants gave their written informed consent to84
participate in the trial. Time restricted feeding sub-85
jects were recruited from September 2016 to January
86
2017 from the Chicago area via advertisements87
placed around the University of Illinois Chicago88
campus. A total of 40 subjects were consented and
89
assessed for eligibility to participate in the time90
restricted feeding intervention (Fig. 1). Of these 4091
subjects, 11 subjects were excluded because they did92
not meet one or more inclusion criteria, and 6 subjects93
declined to participate after qualifying. Inclusion cri- 94
teria was as follows: BMI between 30 and 45kg/m2;95
age between 25 and 65 years; pre-menopausal or 96
post-menopausal (absence of menses for more than 2 97
years); sedentary to lightly active (<7500 steps/d); 98
weight stable for 3 months prior to the beginning 99
of the study (<4 kg weight loss or weight gain); 100
non-diabetic; no history of cardiovascular disease 101
(myocardial infarction or stroke); non-smoker; not 102
a shift worker; and not taking weight loss, lipid- or 103
glucose-lowering medications. 104
2.2. Historical control subject selection 105
Outcome measures were compared to a matched 106
historical control group from a previous weight loss 107
trial performed by our group from October 2011 to 108
January 2015 [10] (Fig. 1). This previous trial imple- 109
mented similar inclusion and exclusion criteria as the 110
present trial, and all control subjects were recruited 111
from the Chicago area via advertisements placed 112
around the University of Illinois Chicago campus. 113
There were 31 control subjects in the previous trial 114
[10]. A stratified random sampling protocol based 115
on age, BMI, and sex was used to match the his- 116
torical control group (n= 23) to that of the time 117
restricted feeding group (n= 23). Subjects were ran- 118
domly selected from each consecutive strata, one-by 119
one, until the sample size of 23 was reached. 120
2.3. Baseline period 121
Before commencing the study, both groups par- 122
ticipated in a 2-week baseline weight stabilization 123
period. All subjects were requested to remain weight 124
stable by consuming their usual diet and not chang- 125
ing their physical activity habits. Body weight was 126
measured weekly at the research center during this 127
period. 128
2.4. Time restricted feeding group protocol 129
Time restricted feeding subjects were instructed to 130
eat ad libitum from 10:00 to 18:00 h daily, and fast 131
from 18:00 to 10:00 h daily. During the 8-h feeding 132
window, there were no restrictions on types or quanti- 133
ties of foods consumed. Moreover, subjects were not 134
required to monitor caloric intake during ad libitum 135
feeding period. During the fasting period, subjects 136
were encouraged to drink plenty of water and were 137
permitted to consume energy-free beverages, such 138
Uncorrected Author Proof
K. Gabel et al. / Time restricted feeding for weight loss 3
Fig. 1. Study flow chart.
black tea, coffee, and diet sodas. Adherence to the 8-h139
time restricted feeding window was measured using140
a daily adherence log, which recorded the times each141
subject started and stopped eating each day. If the log142
indicated that the subject ate within the 8-h window
143
(10:00 to 18:00 h), that day was labeled “adherent”. If144
the log indicated that the subject consumed food out-
145
side of the 8-h feeding window, that day was labeled
146
as “non-adherent”. Adherence to the time restricted
147
feeding diet was assessed as the number of adherent148
days per week.149
2.5. Historical control group protocol150
Historical controls were selected from a previ-151
ous weight loss trial [10] performed by our group152
from 2011–2015. Controls were instructed to main-
153
tain their weight throughout the trial, and not to
154
change their eating or physical activity habits. Con-155
trols visited the research center on a weekly basis for156
weigh-ins. Body composition and metabolic disease157
risk variables were assessed in control subjects every158
12 weeks.
159
2.6. Dietary intake and physical activity
160
Time restricted feeding and control subjects com-
161
pleted a 7-d food record (on 7 consecutive days)162
during the baseline period and week 12. At base-163
line, a dietitian provided 15 min of instruction to each 164
participant on how to complete the food records. 165
These instructions included information and refer- 166
ence guides on how to estimate portion sizes and 167
record food items in sufficient detail to obtain accu- 168
rate estimates of dietary intake. Subjects were not 169
required to weigh foods but were asked to measure 170
the volume of foods consumed with household mea- 171
sures (i.e. measuring cups and measuring spoons). 172
The timing of food intake was also recorded. Food 173
records were collected at the weigh-in at baseline and 174
week 12, and were reviewed by the dietitian for accu- 175
racy and completeness. The food analysis program, 176
Nutritionist Pro (Axxya Systems, Stafford, TX) was 177
used to calculate the total daily intake of energy, fat, 178
protein, carbohydrate, cholesterol, and fiber. All sub- 179
jects were asked to maintain their level of physical 180
activity throughout the entire trial. We assessed activ- 181
ity level as steps/d. Step counts were measured over 182
7-d during the baseline period and at week 12 by 183
a pedometer (Yamax Digi-walker SW-200, Yamax 184
Inc., San Antonio, TX). 185
2.7. Outcome measures 186
2.7.1. Body weight and body composition 187
The primary outcome measure was body weight. 188
Body weight was assessed to the nearest 0.25 kg every 189
week without shoes and in light clothing using a bal- 190
ance beam scale (HealthOMeter, Boca Raton, FL). 191
Uncorrected Author Proof
4K. Gabel et al. / Time restricted feeding for weight loss
Height was assessed during the screening visit using192
a wall-mounted stadiometer (HealthOMeter, Boca
193
Raton, FL) to the nearest 0.1 cm. BMI was assessed194
as kg/m2. Body composition (fat mass, lean mass,195
visceral fat mass) was measured using dual x-ray196
absorptiometry (DXA; iDXA, General Electric Inc).
197
2.7.2. Metabolic disease risk factors
198
Blood pressure and heart rate were measured at
199
baseline and week 12 in triplicate using a digital200
automatic blood pressure/heart rate monitor (Omron201
HEM 705 LP, Kyoto, Japan) with the subject in a202
seated position after a 10-min rest. Twelve-h fast-203
ing blood samples were collected between 5:00 and204
9:00 h at baseline and week 12. The subjects were
205
instructed to avoid exercise, alcohol, and coffee for206
24 h before each visit. Blood was centrifuged for207
10 min at 520 Í g at 4C to separate plasma from208
red blood cells and was stored at –80C until ana-209
lyzed. Fasting plasma total cholesterol, direct LDL210
cholesterol, HDL-cholesterol, triglycerides concen-
211
trations were measured by a commercial lab (Alverno
212
Laboratories, Hammond, IN). Fasting glucose con-213
centrations were measured with a hexokinase reagent214
kit (Abbott, South Pasadena, CA). Fasting insulin was215
assessed as total immunoreactive insulin (Coat-A-
216
Count Insulin, Los Angeles, CA). Insulin resistance
217
(IR) was calculated using the HOMA (Home-
218
ostasis Model Assessment) method, by applying
219
the following formula: [HOMA-IR = Fasting insulin220
(lU/ml) ×Fasting glucose (mg/dL) / 405]. Plasma221
homocysteine was quantified using HPLC with fluo-222
rometric detection.223
2.8. Statistical analyses
224
All data are presented as mean ±standard error
225
of the mean (SEM). Statistical analyses were per-
226
formed using SPSS 24.0 for Windows (SPSS Inc.).
227
A two-tailed P value of less than 0.05 was consid-228
ered statistically significant. Tests for normality were
229
included in the model, and all data were found to be230
normally distributed. For the sample size calculation,
231
we estimated that time restricted feeding and con-232
trol group would reduce body weight by 3% and 0%,233
respectively, by week 12. We calculated that n=19234
participants per group would provide 80% power to235
detect a significant difference of 3% in body weight236
between the time restricted feeding and control group237
at week 12, using a two-tailed independent-samples
238
t-test with = 0.05. We anticipated a dropout rate of239
20%. Thus, we aimed to recruit n= 23 subjects in the 240
time restricted feeding group, assuming that n=19 241
would complete the trial. 242
Differences between the time restricted feeding 243
and control groups at baseline were analyzed by an 244
independent samples t-test (continues variables) or 245
the McNemar test (categorical variables). Data were 246
included for 46 participants, and means were esti- 247
mated using an intention-to-treat analysis using last 248
observation carried forward. Repeated measures two- 249
factor ANOVA with groups (time restricted feeding 250
and control) as the between-subject factor and time 251
(week 1 and 12) as the within-subject factor was used 252
to compare changes in dependent variables between 253
the groups over time. When there was a significant 254
main effect but no interaction, post hoc compar- 255
isons were performed using Bonferroni’s correction 256
to determine differences between group means. 257
3. Results 258
3.1. Baseline characteristics and dropouts 259
As portrayed in Fig. 1, n= 23 subjects began the 260
time restricted feeding intervention and 6 dropped 261
out. No subjects reported dropping out of the time 262
restricted feeding group due to issues with the diet. At 263
baseline, there were no statistically significant differ- 264
ences between the time restricted feeding group and 265
the historical control group for age, sex, ethnicity, 266
weight, height or BMI (Table 1). 267
Table 1
Baseline characteristics1
Time restricted Control Pvalue2
feeding
N2323
Age (y) 50 ±248±2 0.43
Sex (F/M) 20/3 21/2 0.82
Ethnicity 0.69
African American 17 17
Caucasian 3 5
Hispanic 3 1
Weight (kg) 95±392±3 0.34
Height (m) 1.66 ±0.02 1.63 ±0.01 0.29
BMI (kg/m2)35±134±1 0.61
1All values reported as mean ±SEM. 2Pvalues for comparison
of baseline variables between groups using independent samples
t-test (continuous variables) and the McNemar test (categorical
variables).
Uncorrected Author Proof
K. Gabel et al. / Time restricted feeding for weight loss 5
Fig. 2. Weekly adherence to the 8-hour feeding window by the
time restricted feeding group. All values reported as mean ±SEM.
Each bar indicates the mean number of days per week that the
time restricted feeding subjects were compliant with the 8-hour
feeding window.On average, the time restricted feeding group was
compliant with the prescribed eating window (10:00 to 18:00 h) on
5.6 ±0.3 d/week, and this level of adherence did not change over
the course of the trial (P= 0.86, repeated measures ANOVA).
3.2. Adherence to the time restricted feeding268
window269
Subjects in the time restricted feeding group were
270
compliant with the prescribed eating window (10:00271
to 18:00 h) on 5.6 ±0.3 d/week (Fig. 2), and this level272
of adherence did not change over the course of the
273
trial (P= 0.86). At baseline, the time restricted feed-274
ing and control groups reported a similar mean daily275
eating duration of 11 ±1 h (Table 2). By week 12,276
mean daily eating duration in the time restricted feed-277
ing group was significantly shorter (8 ±1 h) than that278
of the control group (11 ±1 h) (group ×time inter-
279
action, P= 0.01). The start of the eating duration in
280
the time restricted feeding group was later than that
281
of the control group during the study (group ×time282
interaction, P= 0.01), and the end of the eating dura-
283
tion was similar between the groups during the study
284
(no group ×time interaction, P= 0.32).285
3.3. Dietary intake and physical activity
286
At baseline, energy intake was similar in the time287
restricted feeding and control groups (Table 2). Dur-288
ing the trial, energy intake decreased in the time289
restricted feeding group by 341 ±53 kcal/d relative290
to controls (group ×time interaction, P= 0.04). Self-291
reported intake of macronutrients, dietary cholesterol
292
and fiber did not differ between groups at baseline or
293
post-treatment. Activity level, measured as steps/d,
294
was similar at baseline in the time restricted feed- 295
ing and control groups, and did not change over the 296
course of the trial in either group. 297
3.4. Body weight and body composition 298
Body weight remained stable during the 2-week 299
baseline period (Fig. 3). Body weight decreased in 300
the time restricted group (–2.6% ±0.5) relative to 301
controls during the 12-week study (group ×time 302
interaction, P< 0.001). BMI decreased in the time 303
restricted feeding group relative to the control group 304
during the trial (group ×time interaction, P< 0.001) 305
(Table 3). There were no statistically significant dif- 306
ferences (i.e. no group ×time interaction) between 307
groups for fat mass, lean mass or visceral fat mass 308
(Table 3). 309
3.5. Metabolic disease risk factors 310
At baseline, there were no differences between 311
groups for any metabolic disease risk factor (Table 3). 312
Systolic blood pressure significantly decreased in 313
the time restricted feeding group (–7 ±2 mm Hg) 314
relative to controls during the study (group×time 315
interaction, P= 0.02). There were no statistically sig- 316
nificant differences (i.e. no group ×time interaction) 317
between groups for diastolic blood pressure, heart 318
rate, total cholesterol, LDL cholesterol, HDL choles- 319
terol, triglycerides, glucose, insulin, HOMA-IR, or 320
homocysteine. 321
4. Discussion 322
This study is the first trial to examine the impact of 323
time restricted feeding on body weight and metabolic 324
disease risk factors in an obese population. We show 325
here that 12 weeks of 8-h time restricted feed- 326
ing (i.e. limiting food intake to 10:00 to 18:00 h 327
daily) decreases body weight by 3% relative to 328
a no-intervention historical control group. We also 329
demonstrate that this fasting regimen produces sig- 330
nificant reductions in systolic blood pressure relative 331
to controls. 332
Adherence to the time restricted feeding window 333
was assessed daily via self-report. Our findings show 334
that subjects were adherent to the prescribed eating 335
window on 6 days per week, and that this level 336
of adherence remained constant throughout the 12- 337
week trial. On average, the time restricted feeding 338
Uncorrected Author Proof
6K. Gabel et al. / Time restricted feeding for weight loss
Table 2
Self-reported dietary intake, eating duration, and physical activity at baseline and week 12 1
Time restricted feeding (n= 23) Control (n= 23) P-value Time ×group 3
Baseline 2Week 12 Baseline 2Week 12
Energy (kcal) 1676 ±114 1335 ±162 1645 ±113 1654 ±191 0.04
Protein (%) 16 ±117±117±117±1 0.40
Carbohydrates (%) 47 ±246±246±245±2 0.61
Fat (%) 37 ±137±237±138±2 0.74
Cholesterol (mg) 279 ±24 214 ±27 275 ±27 265 ±37 0.32
Fiber (g) 16 ±213±114±115±2 0.17
Daily eating duration (h) 11 ±18±111±111±10.01
Start of eating duration (local time, h) 8:30 ±0:30 10:00 ±0:30 9:30 ±0:30 8:30 ±0:30 0.01
End of eating duration (local time, h) 19:30 ±0:30 18:00 ±0:30 20:30 ±0:30 19:30 ±0:30 0.32
Steps/day 6896 ±723 7443 ±880 6148 ±775 6967 ±584 0.84
1All values reported as mean ±SEM. Data for all variables were collected over a 7-d period at baseline (prior to the commencement of the
study) and week 12 in the TRF and control groups. Data were included for 46 participants; means were estimated using an intention-to-treat
analysis using last observation carried forward. 2Baseline variables: No difference between groups for any parameter (Independent samples t-
test). 3Pvalues reported for the time restricted feeding group relative to the control group (group ×time interaction) using repeated-measures
2-factor ANOVA.
Fig. 3. Weight loss by the time restricted feeding group versus con-
trols 1.1All values reported as mean ±SEM. Data were included
for 46 participants; means were estimated using an intention-to-
treat analysis using last observation carried forward. Body weight
remained stable during the 2-week baseline period (week B1 and
week B2). Body weight decreased in the time restricted feeding
group relative to controls during the 12-week intervention period
(P< 0.001 for time ×group interaction).
subjects reduced their daily eating duration by 3 h/d,339
i.e. from 11 h/d to 8h/d. The dropout rate in the time340
restricted feeding group (26%) was high for a short-341
term trial. However, no one in the time restricted
342
feeding group reported dropping out due to issues
343
with the diet. These preliminary findings suggest that344
time restricted feeding may be somewhat well toler-
345
ated over short periods in obese subjects.346
Our findings also indicate that reducing the daily347
eating window to 8-h/d decreases caloric intake by
348
300 kcal/d, without intentional calorie counting. As
349
a result of this daily energy deficit, subjects in the time 350
restricted feeding group lost 3% of body weight 351
over 12 weeks, versus controls. The degree of weight 352
loss demonstrated here is less than what was achieved 353
in the 10-h time restricted feeding study (4%) [11]. 354
This may be due, in part, to the shorter trial dura- 355
tion (3 months) implemented here, when compared 356
to the 10-h time restricted feeding study (4 months) 357
[11]. Degree of energy restriction was also lower in 358
the present study (300 kcal/d deficit), when com- 359
pared to that of the 10-h time restricted feeding study 360
(400 kcal/d deficit) [11]. Our results, however, are 361
similar to the 4-8-h time restricted feeding trials 362
which produced 1–3% body weight reductions [12, 363
13]. 364
In comparison to other forms of intermittent fast- 365
ing [4–10], time restricted feeding appears to produce 366
less weight loss. For instance, after 12 weeks of alter- 367
nate day fasting, body weight typically decreases by 368
4–6% from baseline [4–10]. We speculate that this 369
difference in weight loss is due to greater overall 370
caloric restriction achieved with other forms of inter- 371
mittent fasting, versus time restricted feeding. Accu- 372
mulating evidence suggests that alternate day fasting 373
produces an average caloric deficit of 25–35% daily 374
[10, 16], whereas time restricted feeding may only 375
produce a 20% caloric deficit daily [11]. The greater 376
degree of energy restriction achieved with alternate 377
day fasting is most likely the result of the vigilant 378
calorie counting on fast days. Since time restricted 379
feeding does not require subjects to monitor calorie 380
intake at all, this may explain why the average caloric 381
deficit achieved with time restricted feeding is lower. 382
Uncorrected Author Proof
K. Gabel et al. / Time restricted feeding for weight loss 7
Table 3
Body composition and metabolic disease risk factors after 12 weeks1
Time restricted feeding (n= 23) Control (n= 23) P-value Time ×group3
Baseline2Week 12 Baseline2Week 12
Body weight (kg) 95 ±392±392±392±3<0.001
Fat mass (kg)442 ±240±237±237±2 0.23
Lean mass (kg) 50 ±250±253±253±2 0.12
Visceral fat mass (kg) 1.2 ±0.1 1.1 ±0.1 1.2 ±0.2 1.2 ±0.2 0.19
BMI (kg/m2)35±134±134±134±1<0.001
Systolic blood pressure (mm Hg) 128 ±4 121±3 123 ±4 124 ±30.02
Diastolic blood pressure (mm Hg) 83 ±282±281±282±2 0.41
Heart rate (bpm) 69 ±271±273±273±3 0.33
Total cholesterol (mg/dl) 177±7 178 ±9 192 ±7 185 ±7 0.15
LDL cholesterol (mg/dl) 108 ±5 110 ±7 114±7 112 ±6 0.54
HDL cholesterol (mg/dl) 48 ±249±261±355±2 0.11
Triglycerides (mg/dl)4105 ±11 93 ±989±789±11 0.43
Fasting glucose (mg/dl) 79±482±287±287±2 0.77
Fasting insulin (uIU/ml)48.3 ±1.0 5.7 ±0.7 9.2 ±1.4 10.3 ±1.9 0.16
HOMA-IR41.6 ±0.2 1.0 ±0.2 2.0 ±0.3 2.2 ±0.4 0.21
Homocysteine (mol/l)49.9 ±0.6 9.0 ±0.5 10.1 ±0.5 9.4 ±0.5 0.83
1All values reported as mean ±SEM. Data were included for 46 participants; means were estimated using an intention-to-treat analysis using
last observation carried forward. HOMA-IR: Homeostatic model assessment Insulin resistance; RMR: Resting metabolic rate. 2Baseline
variables: No difference between groups for any parameter (Independent samples t-test). 3Pvalues reported for the time restricted feeding
group relative to the control group (group×time interaction) using repeated-measures 2-factor ANOVA. 4Significant main effect of time,
P< 0.05.
One potential confound in the current study is the383
lack of an objective measure to assess eating dura-
384
tion. As time restricted feeding is a recent concept,
385
methods to objectively record eating time have yet
386
to be optimized. Self-reporting of eating duration, as
387
used in the current study, may not be optimal. An app-388
based recording of all eating events was used in the389
10-h time restricted feeding study, and found a self-
390
reporting error of 10% [11]. Objective methods of391
recording eating events show a mean eating duration
392
that is different from what is widely believed [11].393
A study assessing eating pattern among non-shift
394
worker adults found the median daily eating duration
395
can be 15-h or longer, and less than 15% of adults
396
eat for less than a 12-h duration [11]. In comparison,
397
in the present study, the self-reported baseline eating398
duration was 11 h, which is likely inaccurate. Our399
study also permitted the consumption of low energy400
drinks including coffee, tea, and diet soda. These401
drinks contain caffeine, which is known to perturb402
circadian rhythm [17]. Since time restricted feeding403
is based on the principle of circadian rhythm regu-
404
lation of metabolism, low-energy caffeinated drinks405
may not count significantly towards energy consump-406
tion, but can have significant impact on circadian407
regulation.408
Future trials in this area can be improved by using409
objective measures to better assess daily eating dura-410
tions. It will also be of interest to investigate whether 411
shorter eating windows (4–6 h) produce a degree of 412
weight loss that is comparable to that of alternate day 413
fasting and 5:2. Moreover, how the placement of the 414
feeding window influences weight loss and adher- 415
ence will also be important to examine. We chose to 416
prescribe a feeding window of 10:00 to 18:00 h, so 417
that the intervention would be standardized across all 418
subjects. We assumed that this window would pro- 419
duce maximal adherence, as it would cause minimal 420
disruption to the typical eating schedule (i.e. sub- 421
jects could still have their breakfast in the morning, 422
lunch in the early afternoon, and dinner in the early 423
evening). However, recent trials [18, 19] have found 424
that consuming larger meals earlier in the day produce 425
better weight loss than similar sized meals consumed 426
later in the evening. Whether weight loss and adher- 427
ence can be improved by shifting the eating window 428
earlier in the day warrants investigation. 429
Metabolic disease risk indicators remained rel- 430
atively unaffected by the time restricted feeding 431
regimen. Systolic blood pressure was the only 432
parameter that improved over the course of the 433
study, relative to controls. Reductions in insulin, 434
insulin resistance, triglycerides, and homocysteine 435
were also observed over time, but these effects were 436
not statistically different from the control group. 437
In the study by Moro et al. [12], plasma lipids 438
Uncorrected Author Proof
8K. Gabel et al. / Time restricted feeding for weight loss
and inflammatory factors also remained unchanged439
with 8-h time restricted feeding. It is likely that the
440
degree of weight loss produced by 8-h time restricted441
feeding was not large enough to improve these442
outcome measures. Accumulating evidence suggests443
that > 5% weight loss is required to improve plasma
444
lipid concentrations and glucoregulatory factors [20].445
It should also be noted that the obese subjects in the446
present study were metabolically healthy at baseline,447
i.e. their blood pressure, plasma lipid, glucose, and
448
insulin levels were all within the normal range.449
Previous work indicates that intermittent fasting450
regimens [4, 8, 10] and other lifestyle regimens [21,
451
22] have little effect on cardiometabolic disease452
risk factors in healthy obese subjects. It will be of
453
interest to examine whether time restricted feeding454
can improve these risk factors in other groups of455
obese patients, such as those with compromised
456
insulin sensitivity or dyslipidemia [23, 24].457
This study has several limitations. First, the study458
was not a randomized controlled trial. We compared459
the effects of time restricted feeding to a matched his-460
torical control group from a previous weight loss trial461
conducted by our group. The trial [10] from which462
the controls were selected was conducted between
463
2011–2015. As such, the lapse of up to five years
464
between trials could have influenced what the con-465
trol subjects knew about weight control, and what
466
foods were available in the marketplace due to sea-467
sonality. These issues should be considered when468
interpreting the present findings. In order to truly
469
determine the effect of time restricted feeding on470
body weight and other metabolic disease variables,
471
future trials should implement a randomized design
472
where controls are enrolled concurrently. Second, the473
study was quite short (12 weeks). Longer-term tri-474
als will be needed to determine the degree of weight475
loss that can be achieved with time restricted feeding.476
Third, adherence and dietary intake were assessed477
by self-report, thus our estimates of eating dura-
478
tion and caloric deficit may be inaccurate [25, 26].479
Implementing mobile apps to assess adherence in
480
real-time [11] will help determine how well subjects481
can adhere to the prescribed eating window. Fourth,482
subjects completed a 7-d food record during the base-483
line period, which may have influenced their eating484
behaviors [27]. Recent findings suggest that subjects485
are more likely to report foods that are considered486
healthy and socially desirable, and omit foods that
487
are considered unhealthy, when completing study-
488
related food records [27]. Fifth, our study involved
489
only metabolically healthy obese subjects, so our
490
findings cannot be generalized to other population 491
groups. 492
In summary, these findings suggest that 8-h time 493
restricted feeding produces mild caloric restriction 494
and weight loss in obese adults, without intentional 495
calorie counting. This diet may also offer some clini- 496
cal benefit by reducing systolic blood pressure. These 497
preliminary data offer promise for the use of time 498
restricted feeding as a weight loss technique in obese 499
adults, but longer-term, larger-scale randomized con- 500
trolled trials will be required before solid conclusions 501
can be reached. 502
Acknowledgments 503
KG designed the research, conducted the clinical 504
trial, analyzed the data, performed the statistical anal- 505
ysis, and wrote the manuscript; KKH, NH, JS, CMK, 506
and JFT assisted with the conduction of the clinical 507
trial; SP assisted with data interpretation and wrote 508
the manuscript; KAV designed the research, analyzed 509
the data, and wrote the manuscript. 510
Funding 511
University of Illinois Chicago Campus Research 512
Board Pilot Grant; National Institutes of Health 513
R01HL106228, F32DK107157, T32HL007909. 514
Trial registration 515
Clinicaltrials.gov NCT02948517. 516
Disclosure 517
Dr. Varady received author fees from Hachette 518
Book Group for the book, “The Every Other Day 519
Diet”. Dr. Panda received author fees from Rodale 520
Books for the upcoming book, “The Circadian Code”. 521
The other authors have no conflicts of interest to 522
report. 523
References 524
[1] Longo VD, Mattson MP.Fasting: Molecular mechanisms and 525
clinical applications. Cell Metab. 2014;19(2):181-92. 526
Uncorrected Author Proof
K. Gabel et al. / Time restricted feeding for weight loss 9
[2] Longo VD, Panda S. Fasting, Circadian Rhythms, and
527
Time-Restricted Feeding in Healthy Lifespan. Cell Metab.528
2016;23(6):1048-59.529
[3] Chaix A, et al. Time-restricted feeding is a preventative
530
and therapeutic intervention against diverse nutritional chal-531
lenges. Cell Metab. 2014;20(6):991-1005.532
[4] Bhutani S, et al. Alternate day fasting and endurance exer-533
cise combine to reduce body weight and favorably alter
534
plasma lipids in obese humans. Obesity (Silver Spring).
535
2013;21(7):1370-9.
536
[5] Catenacci VA, et al. A randomized pilot study com-
537
paring zero-calorie alternate-day fasting to daily caloric538
restriction in adults with obesity. Obesity (Silver Spring).539
2016;24(9):1874-83.540
[6] Harvie MN, et al. The effects of intermittent or continuous541
energy restriction on weight loss and metabolic disease risk
542
markers: A randomized trial in young overweight women.543
Int J Obes (Lond). 2011;35(5):714-27.
544
[7] Heilbronn LK, et al. Alternate-day fasting in nonobese sub-
545
jects: Effects on body weight, body composition, and energy546
metabolism. Am J Clin Nutr. 2005;81(1):69-73.547
[8] Hoddy KK, et al. Meal timing during alternate day fasting:548
Impact on body weight and cardiovascular disease risk in549
obese adults. Obesity (Silver Spring). 2014;22(12):2524-31.550
[9] Klempel MC, Kroeger CM, Varady KA. Alternate day fasting551
(ADF) with a high-fat diet produces similar weight loss and
552
cardio-protection as ADF with a low-fat diet. Metabolism.553
2013;62(1):137-43.554
[10] Trepanowski JF, et al. Effect of Alternate-Day Fasting on555
Weight Loss, Weight Maintenance, and Cardioprotection
556
Among Metabolically Healthy Obese Adults: A Randomized557
Clinical Trial. JAMA Intern Med. 2017.558
[11] Gill S, Panda S. A Smartphone App Reveals Erratic Diurnal559
Eating Patterns in Humans that Can Be Modulated for Health560
Benefits. Cell Metab. 2015;22(5):789-98.561
[12] Moro T, et al. Effectsof eight weeks of time-restricted feeding562
(16/8) on basal metabolism, maximal strength, body com-
563
position, inflammation, and cardiovascular risk factors in
564
resistance-trained males. J Transl Med. 2016;14(1):290.
565
[13] Tinsley GM, et al. Time-restricted feeding in young men per-566
forming resistance training: A randomized controlled trial.
567
Eur J Sport Sci. 2017;17(2):200-07.568
[14] Jensen MD, et al. 2013 AHA/ACC/TOS guideline for the569
management of overweight and obesity in adults: A report of570
the American College of Cardiology/American Heart Asso-571
ciation Task Force on Practice Guidelines and The Obesity572
Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985-3023.573
[15] Magkos F, et al. Effects of Moderate and Subsequent 574
Progressive Weight Loss on Metabolic Function and Adi- 575
pose Tissue Biology in Humans with Obesity. Cell Metab. 576
2016;23(4):591-601. 577
[16] Klempel MC, et al. Dietary and physical activity adaptations 578
to alternate day modified fasting: Implications for optimal 579
weight loss. Nutr J. 2010;9:35. 580
[17] Burke TM, et al. Effects of caffeine on the human 581
circadian clock in vivo and in vitro. Sci Transl Med. 582
2015;7(305):305ra146. 583
[18] Garaulet M, et al. Timing of food intake predicts weight loss 584
effectiveness. Int J Obes (Lond). 2013;37(4):604-11. 585
[19] Jakubowicz D, et al. High caloric intake at breakfast vs. 586
dinner differentially influences weight loss of overweight 587
and obese women. Obesity (Silver Spring). 2013;21(12): 588
2504-12. 589
[20] Ryan DH, Yockey SR. Weight Loss and Improvement in 590
Comorbidity: Differences at 5%, 10%, 15%, and Over. Curr 591
Obes Rep. 2017;6(2):187-94. 592
[21] Janiszewski PM, Ross R. Effects of weight loss among 593
metabolically healthy obese men and women. Diabetes Care. 594
2010;33(9):1957-9. 595
[22] Kantartzis K, et al. Effects of a lifestyle intervention in 596
metabolically benign and malign obesity. Diabetologia. 597
2011;54(4):864-8. 598
[23] Barnosky AR, et al. Intermittent fasting vs daily calorie 599
restriction for type 2 diabetes prevention: A review of human 600
findings. Transl Res. 2014;164(4):302-11. 601
[24] Harvie M, Howell A. Potential Benefits and Harms of Inter- 602
mittent Energy Restriction and Intermittent Fasting Amongst 603
Obese, Overweight and Normal Weight Subjects-A Narrative 604
Review of Human and Animal Evidence. Behav Sci (Basel). 605
2017;7(1). 606
[25] Black AE, Cole TJ. Within- and between-subject varia- 607
tion in energy expenditure measured by the doubly-labelled 608
water technique: Implications for validating reported dietary 609
energy intake. Eur J Clin Nutr. 2000;54(5):386-94. 610
[26] Lichtman SW, et al. Discrepancy between self-reported and 611
actual caloric intake and exercise in obese subjects. N Engl 612
J Med. 1992;327(27):1893-8. 613
[27] Ortega RM, P.-R.C., Lopez-Sobaler AM. Dietary assessment 614
methods: Dietary records. Nutr Hosp. 2015;31:38-45. 615
... Despite the significant weight loss, exercise combined with ADF did not improve sleep quality or duration in patients with nonalcoholic fatty liver disease [39]. On the other hand, it is claimed that TRE with a 10-hour eating window has high compliance and similar effects like an 8-hour eating window, on various clinical outcomes in patients [38,40]. However, none of the studies addressed the combination effect of 10-hour TRE plus RT on body composition and psychological outcomes (mood swings, sleep quality) in young adults with overweight or obesity. ...
... Blood pressure values among obese adults with stable physiological and metabolic health remain relatively unaffected by TRE or other dietary regimens [71,72]. In contrast to our findings, 8-hour TRE (12 weeks) decreased SBP without changing DBP or other metabolic variables in adults with obesity [40]. In addition, both types of exercise programs were shown to decrease SBP and DBP in obese adults, and a greater extent of decrease was observed in patients with hypertension [73]. ...
... TRE alone did not influence the sleep quality of participants, but the physiological reasons for this remain to be investigated. Similar to our findings, Gabel et al. and Wilkinson et al. also reported no change in sleep quality after TRE intervention, regardless of a noticeable (3%) weight loss [38,40]. We assume that a greater degree of weight loss with TRE may contribute to a significant improvement in sleep quality. ...
Article
Full-text available
Background/objective: Dietary restriction or exercise regimens can promote weight loss or physical fitness among patients with obesity. However, intervention-associated adverse effects may impede patients' motivation to participate in dietary/exercise interventions. We examined the effects of time restricted eating (TRE) with or without resistance training (RT) on body composition, mood profile, and sleep quality in young college adults with overweight or obesity. Methods: Fifty-four young college students with overweight/obesity were randomized into control (CON), TRE, RT, and TRE plus RT (TRE+RT) trials. The TRE trials restricted to an eating window of 10-hour/day for 8-week. The RT trials performed supervised resistance exercise, while the control trial maintained a regular lifestyle. Changes in body composition variables, blood pressure, mood status, and sleep quality were measured before and after the intervention. Results: TRE intervention alone or in combination with RT significantly (p < 0.01) decreased body weight (>2 kg) and BMI (~1 kg/m2) in adults with overweight/obesity. Both RT alone and combined with TRE substantially decreased fat mass by 1.1 ± 0.5 and 3.2 ± 0.4 kg, respectively. The decreased fat mass was greater in the combination trial than in the RT trial, whereas TRE alone had no effect. In contrast, fat-free mass was significantly (p < 0.01) decreased with TRE (-2.3 ± 06 kg), increased with RT (1.6 ± 0.3 kg), and was stably maintained with combination interventions. The reduced waist and hip circumferences in the TRE (p < 0.01) were similar to those in the TRE+RT trials, however, RT alone had no effect. Time and group interaction showed a large effect size (partial eta squared) for all body composition variables. In addition, RT with or without TRE notably decreased diastolic blood pressure (RT: -5.5 ± 1.9 mmHg, TRE+RT: -4.1 ± 1.5 mmHg, p < 0.05). Mild anxiety levels at baseline in RT (4.8 ± 2.6) and TRE+RT (4.1 ± 3) trials were found to be normal at postintervention in TRE+RT (3.6 ± 1.7) but not in RT (5.6 ± 3.5). No depression or stress was recorded among the participants during the intervention. The reported poor sleep quality among participants at baseline was significantly improved with RT (4.8 ± 2.9; p < 0.05), and tended to improve with TRE+RT interventions (4.5 ± 1.9). Conclusions: 10-hour TRE is beneficial for weight/fat loss without affecting mood status. However, TRE combined with RT might be more effective for weight/fat loss, maintaining muscle mass, and good quality of sleep among young adults with overweight or obesity.
... In a 36-month longitudinal study consisting of 99 elderly subjects with mild cognitive impairment, consistent adherence to a TRE diet was associated with significant cognitive enhancements, decreased markers of DNA damage and inflammation, and improved markers in oxidative stress [6]. Because TRE diets have been applied as a weight management strategy in overweight individuals, safety is a primary concern as HD is known for causing weight loss, especially in later disease stages [22,23]. It is interesting and reassuring that a study evaluating the safety and tolerability of TRE in healthy midlife and older adults found that the diet had no influence on body mass, fat-free mass, bone density, or nutrient intake [24]. ...
... Thus, we must rely on existing data on TRE intervention in other populations. To detect differences in the percent change in body weight from baseline to follow-up, assuming a standard deviation of 2.4% from Gabel et al., we will have 95% power to detect a difference as low as 2.5% change in body weight in n = 15 with two-sided Type I error of 0.05 [22]. To detect differences in plasma neurofilament light protein (NfL) from baseline to follow-up, assuming a standard deviation of 0.65 log pg/ml from Byrne et al., we will have 90% power to detect a difference as low as 15% in plasma NfL between baseline and follow-up in n = 20 with two-sided Type I error of 0.05 [26]. ...
Article
Full-text available
Huntington’s disease (HD) is a devastating neurodegenerative disorder characterized by a variety of debilitating symptoms including abnormal motor control, cognitive impairment, and psychiatric disturbances. Despite significant efforts, efficacious treatments to alter the course of HD remain elusive, highlighting the need to explore new therapeutic strategies, including lifestyle changes that may delay the onset of symptoms and slow disease progression. Recent research indicates that time-restricted eating (TRE), a type of intermittent fasting where caloric intake is confined to a specific time window each day, may be beneficial in treating neurodegenerative diseases like HD. TRE has been found to enhance mitochondrial function, stimulate autophagy, lower oxidative stress, and improve cognitive performance. Although TRE has shown potential in HD animal models and non-HD populations, it has yet to be analyzed for safety, feasibility, and efficacy in persons with HD. Therefore, we propose a prospective interventional, open-label, single-arm, pilot study of 25 participants with late prodromal and early manifest HD to evaluate participant adherence to TRE diet – specifically, maintaining a 6-8-hour eating window every day for 12 weeks. Secondary measures will include pre- versus post-intervention assessment of body composition via bioelectrical impedance analysis, vital signs and safety labs, serum biomarkers of neurodegeneration, and standard HD behavioral, cognitive, and motor function clinical scales. Additional exploratory measures will evaluate sleep quality, physical activity, mood, dietary composition, and mitochondrial function. We expect that the diet will be safe, feasible, and may also improve biomarkers of disease progression in persons with HD. We anticipate this study will lay the foundation for future large-scale clinical trials to further evaluate the clinical efficacy of TRE in HD. This study has been registered on July 8, 2024 with ClinicalTrials.gov registration number NCT06490367 (https://clinicaltrials.gov/study/NCT06490367).
... However, a modern lifestyle with unlimited food availability around the clock, and irregular sleeping patterns interfere with this evolutionary energy balance system and are important contributary factors to overweight, insulin resistance and progression to T2D [3][4][5][6] . Time-restricted eating (TRE) has gained attention due to its potential to reduce body weight, improve insulin sensitivity, and reduce blood pressure in individuals with overweight, obesity, and/or T2D [7][8][9] . However, in a recent study (the RESET trial) we reported that 3 months of 10-h per day TRE in overweight or obese individuals at high risk of T2D only led to minor and not clinically relevant effects of TRE over habitual living on body weight 10 inferring that TRE may not always be effective to cause weight loss as this depends on the clinical phenotype and the exact TRE design. ...
Article
Full-text available
Overweight and obesity are linked to mitochondrial alterations, impaired glucose tolerance and a high risk of type 2 diabetes. Time-restricted eating (TRE) may aid in facilitating weight loss to prevent diabetes. Here, we investigated if TRE in individuals with overweight and prediabetes or obesity affects mitochondrial bioenergetics of peripheral blood mononuclear cells (PBMCs) and platelets using the Seahorse extracellular flux technology. In a 3-month randomized controlled trial, PBMCs/platelets were analyzed from 52 participants before and after a TRE intervention with a 10-h eating window or habitual living. PBMC and platelet respiratory function was evaluated through sequential addition of substrates, uncouplers, and inhibitors in living cells. After 3 months, there were no statistically significant differences in mitochondrial respiration within or between the TRE and control groups. Association analyses between PBMC/platelet respiration and clinical parameters including body mass index and fat mass showed no significant effects. In conclusion, 3 months of 10-h TRE does not alter the mitochondrial bioenergetics of PBMCs and platelets in individuals with high risk of type 2 diabetes.
Article
Background: This randomized controlled study sought to determine the effect of intermittent fasting on anthropometric measurements, fibroblast growth factor (FGF)-21, and autophagy markers, as well as on hepatic steatosis and fibrosis levels in overweight or obese patients with metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: Patients were randomly assigned into two groups: received a dietary treatment involving 22–25 kcal/kg/day of energy for 8 weeks and followed the same dietary intervention and a 16:8 pattern. The extent of hepatic steatosis and fibrosis was determined using transient elastography on a FibroScan® device. The controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), determined by transient elastography, reflect hepatic steatosis and fibrosis, respectively. In duplicate, serum levels of FGF-21, Beclin-1, and ATG-5 were determined using enzyme-linked immunosorbent assay. Results: The study included 48 patients with a mean age of 48.2 ± 1.4 years (27 female and 21 male). Improvements in anthropometric measurement and CAP and LSM levels and a decrease in serum FGF-21 levels were found in both groups (p < 0.05). Changes in the CAP and FGF-21 levels were higher in the energy + time-restricted diet group (p < 0.05). Autophagy-related protein (ATG)-5 levels increased only in the energy + time-restricted diet group [(0.74 (0.46–1.29) ng/mL vs. 0.95 (0.73–1.32) ng/mL, p = 0.03]. Conclusions: Intermittent fasting was potentially practical in the management of MAFLD. In particular, changes in FGF-21 and ATG-5 levels indicate the potential of intermittent fasting to regulate metabolic processes and autophagy. However, methodological limitations should be taken into consideration when interpreting the study results.
Article
Full-text available
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a public health concern, linked with immune-metabolic dysfunction. While lifestyle and dietary modifications remain the cornerstone of MASLD management, the optimal dietary approach remains uncertain. Objectives: This systematic review aims to investigate the impact of model dietary patterns on metabolic outcomes in patients with MASLD and evaluate their effects in individuals with coexisting metabolic conditions, such as obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM). Methods: To conduct the review, PubMed, Scopus, Google Scholar, Cochrane CENTRAL, and ClinicalTrials.gov databases were searched for Randomized Controlled Trials (RCTs) on the adult population, published between January 2019 and September 2024, following PRISMA principles. The quality of the included RCTs was assessed qualitatively based on study characteristics. Results: The main findings of this review demonstrated that the use of interventions with dietary model based on Mediterranean diet (MED) and intermittent fasting (IF) approaches, such as alternative-day fasting (ADF) and time-restricted feeding regimens (TRF) may have potential in reducing body weight, BMI, and waist circumference, with additional benefits of improving glycemic control and reducing inflammation. The effects on hepatic functions, although limited, may be linked with reduced enzyme activity and liver stiffness. Additionally, the use of lacto-ovo-vegetarian diet (LOV-D) and the Dietary Approaches to Stop Hypertension (DASH) diet may offer additional health benefits, including blood pressure management. Conclusions: This review suggests that MED and IF-based strategies may reduce BW, improve glycemic control, and lower inflammation, with potential benefits for hepatic function. Further long-term studies are needed to confirm these effects and underlying mechanisms, which will allow for the optimization of protocols and ensure their safety in MASLD.
Article
Full-text available
Purpose of review: One begins to see improvement in glycemic measures and triglycerides with small amounts of weight loss, but with greater levels of weight loss there is even greater improvement. In fact, the relationship between weight loss and glycemia is one that is very close. Recent findings: This is fortunate for diabetes prevention; it takes only small amounts of weight loss to prevent progression to type 2 diabetes from impaired glucose tolerance, and after the 10 kg of weight loss, one cannot demonstrate much additional improvement in risk reduction. Modest weight loss (5 to 10%) is also associated with improvement in systolic and diastolic blood pressure and HDL cholesterol. With all these risk factors, more weight loss produces more improvement. Further, for patients with higher BMI levels (>40 kg/m(2)), the ability to lose the same proportion of weight with lifestyle intervention is equal to that of those with lower BMI levels, and there is equal benefit in terms of risk factor improvement with modest weight loss. For some comorbid conditions, more weight loss is needed-10 to 15%-to translate into clinical improvement. This is true with obstructive sleep apnea and non-alcoholic steatotic hepatitis. There is a graded improvement in improvements in measures of quality of life, depression, mobility, sexual dysfunction, and urinary stress incontinence, whereby improvements are demonstrable with modest weight loss (5-10%) and with further weight loss there are further improvements. For polycystic ovarian syndrome and infertility, modest weight loss (beginning at 2-5%) can bring improvements in menstrual irregularities and fertility. Moderate weight loss (5-10%) has been shown to be associated with reduced health care costs. Reduction in mortality may take more than 10% weight loss, although definitive studies have not been done to demonstrate that weight loss per se is associated with mortality reduction. Clinicians in medical weight management should bear in mind that the target should be health improvement rather than a number on the scale. The individual patient's targeted health goal should be assessed for response rather than a prescribed percentage weight loss.
Article
Full-text available
Intermittent energy restriction (IER) has become popular as a means of weight control amongst people who are overweight and obese, and is also undertaken by normal weight people hoping spells of marked energy restriction will optimise their health. This review summarises randomised comparisons of intermittent and isoenergetic continuous energy restriction for weight loss to manage overweight and obesity. It also summarises the potential beneficial or adverse effects of IER on body composition, adipose stores and metabolic effects from human studies, including studies amongst normal weight subjects and relevant animal experimentation. Six small short term (<6 month) studies amongst overweight or obese individuals indicate that intermittent energy restriction is equal to continuous restriction for weight loss, with one study reporting greater reductions in body fat, and two studies reporting greater reductions in HOMA insulin resistance in response to IER, with no obvious evidence of harm. Studies amongst normal weight subjects and different animal models highlight the potential beneficial and adverse effects of intermittent compared to continuous energy restriction on ectopic and visceral fat stores, adipocyte size, insulin resistance, and metabolic flexibility. The longer term benefits or harms of IER amongst people who are overweight or obese, and particularly amongst normal weight subjects, is not known and is a priority for further investigation.
Article
Full-text available
Background Intermittent fasting (IF) is an increasingly popular dietary approach used for weight loss and overall health. While there is an increasing body of evidence demonstrating beneficial effects of IF on blood lipids and other health outcomes in the overweight and obese, limited data are available about the effect of IF in athletes. Thus, the present study sought to investigate the effects of a modified IF protocol (i.e. time-restricted feeding) during resistance training in healthy resistance-trained males. Methods Thirty-four resistance-trained males were randomly assigned to time-restricted feeding (TRF) or normal diet group (ND). TRF subjects consumed 100 % of their energy needs in an 8-h period of time each day, with their caloric intake divided into three meals consumed at 1 p.m., 4 p.m., and 8 p.m. The remaining 16 h per 24-h period made up the fasting period. Subjects in the ND group consumed 100 % of their energy needs divided into three meals consumed at 8 a.m., 1 p.m., and 8 p.m. Groups were matched for kilocalories consumed and macronutrient distribution (TRF 2826 ± 412.3 kcal/day, carbohydrates 53.2 ± 1.4 %, fat 24.7 ± 3.1 %, protein 22.1 ± 2.6 %, ND 3007 ± 444.7 kcal/day, carbohydrates 54.7 ± 2.2 %, fat 23.9 ± 3.5 %, protein 21.4 ± 1.8). Subjects were tested before and after 8 weeks of the assigned diet and standardized resistance training program. Fat mass and fat-free mass were assessed by dual-energy x-ray absorptiometry and muscle area of the thigh and arm were measured using an anthropometric system. Total and free testosterone, insulin-like growth factor 1, blood glucose, insulin, adiponectin, leptin, triiodothyronine, thyroid stimulating hormone, interleukin-6, interleukin-1β, tumor necrosis factor α, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides were measured. Bench press and leg press maximal strength, resting energy expenditure, and respiratory ratio were also tested. ResultsAfter 8 weeks, the 2 Way ANOVA (Time * Diet interaction) showed a decrease in fat mass in TRF compared to ND (p = 0.0448), while fat-free mass, muscle area of the arm and thigh, and maximal strength were maintained in both groups. Testosterone and insulin-like growth factor 1 decreased significantly in TRF, with no changes in ND (p = 0.0476; p = 0.0397). Adiponectin increased (p = 0.0000) in TRF while total leptin decreased (p = 0.0001), although not when adjusted for fat mass. Triiodothyronine decreased in TRF, but no significant changes were detected in thyroid-stimulating hormone, total cholesterol, high-density lipoprotein, low-density lipoprotein, or triglycerides. Resting energy expenditure was unchanged, but a significant decrease in respiratory ratio was observed in the TRF group. Conclusions Our results suggest that an intermittent fasting program in which all calories are consumed in an 8-h window each day, in conjunction with resistance training, could improve some health-related biomarkers, decrease fat mass, and maintain muscle mass in resistance-trained males.
Article
Full-text available
A randomized controlled trial was conducted to examine eight weeks of resistance training (RT) with and without time-restricted feeding (TRF) in order to assess nutrient intake and changes in body composition and muscular strength in young recreationally active males. The TRF programme consisted of consuming all calories within a four-hour period of time for four days per week, but included no limitations on quantities or types of foods consumed. The RT programme was performed three days per week and consisted of alternating upper and lower body workouts. For each exercise, four sets leading to muscular failure between 8 and 12 repetitions were employed. Research visits were conducted at baseline, four, and eight weeks after study commencement. Measurements of total body composition by dual-energy X-ray absorptiometry and muscle cross-sectional area by ultrasound were obtained. Upper and lower body strength and endurance were assessed, and four-day dietary records were collected. TRF reduced energy intake by ∼650 kcal per day of TRF, but did not affect total body composition within the duration of the study. Cross-sectional area of the biceps brachii and rectus femoris increased in both groups. Effect size data indicate a gain in lean soft tissue in the group that performed RT without TRF (+2.3 kg, d = 0.25). Upper and lower body strength and lower body muscular endurance increased in both groups, but effect sizes demonstrate greater improvements in the TRF group. Overall, TRF reduced energy intake and did not adversely affect lean mass retention or muscular improvements with short-term RT in young males.
Article
Importance: Alternate-day fasting has become increasingly popular, yet, to date, no long-term randomized clinical trials have evaluated its efficacy. Objective: To compare the effects of alternate-day fasting vs daily calorie restriction on weight loss, weight maintenance, and risk indicators for cardiovascular disease. Design, setting, and participants: A single-center randomized clinical trial of obese adults (18 to 64 years of age; mean body mass index, 34) was conducted between October 1, 2011, and January 15, 2015, at an academic institution in Chicago, Illinois. Interventions: Participants were randomized to 1 of 3 groups for 1 year: alternate-day fasting (25% of energy needs on fast days; 125% of energy needs on alternating "feast days"), calorie restriction (75% of energy needs every day), or a no-intervention control. The trial involved a 6-month weight-loss phase followed by a 6-month weight-maintenance phase. Main outcomes and measures: The primary outcome was change in body weight. Secondary outcomes were adherence to the dietary intervention and risk indicators for cardiovascular disease. Results: Among the 100 participants (86 women and 14 men; mean [SD] age, 44 [11] years), the dropout rate was highest in the alternate-day fasting group (13 of 34 [38%]), vs the daily calorie restriction group (10 of 35 [29%]) and control group (8 of 31 [26%]). Mean weight loss was similar for participants in the alternate-day fasting group and those in the daily calorie restriction group at month 6 (-6.8% [95% CI, -9.1% to -4.5%] vs -6.8% [95% CI, -9.1% to -4.6%]) and month 12 (-6.0% [95% CI, -8.5% to -3.6%] vs -5.3% [95% CI, -7.6% to -3.0%]) relative to those in the control group. Participants in the alternate-day fasting group ate more than prescribed on fast days, and less than prescribed on feast days, while those in the daily calorie restriction group generally met their prescribed energy goals. There were no significant differences between the intervention groups in blood pressure, heart rate, triglycerides, fasting glucose, fasting insulin, insulin resistance, C-reactive protein, or homocysteine concentrations at month 6 or 12. Mean high-density lipoprotein cholesterol levels at month 6 significantly increased among the participants in the alternate-day fasting group (6.2 mg/dL [95% CI, 0.1-12.4 mg/dL]), but not at month 12 (1.0 mg/dL [95% CI, -5.9 to 7.8 mg/dL]), relative to those in the daily calorie restriction group. Mean low-density lipoprotein cholesterol levels were significantly elevated by month 12 among the participants in the alternate-day fasting group (11.5 mg/dL [95% CI, 1.9-21.1 mg/dL]) compared with those in the daily calorie restriction group. Conclusions and relevance: Alternate-day fasting did not produce superior adherence, weight loss, weight maintenance, or cardioprotection vs daily calorie restriction. Trial registration: clinicaltrials.gov Identifier: NCT00960505.
Article
Objective: To evaluate the safety and tolerability of alternate-day fasting (ADF) and to compare changes in weight, body composition, lipids, and insulin sensitivity index (Si) with those produced by a standard weight loss diet, moderate daily caloric restriction (CR). Methods: Adults with obesity (BMI ≥30 kg/m(2) , age 18-55) were randomized to either zero-calorie ADF (n = 14) or CR (-400 kcal/day, n = 12) for 8 weeks. Outcomes were measured at the end of the 8-week intervention and after 24 weeks of unsupervised follow-up. Results: No adverse effects were attributed to ADF, and 93% completed the 8-week ADF protocol. At 8 weeks, ADF achieved a 376 kcal/day greater energy deficit; however, there were no significant between-group differences in change in weight (mean ± SE; ADF -8.2 ± 0.9 kg, CR -7.1 ± 1.0 kg), body composition, lipids, or Si. After 24 weeks of unsupervised follow-up, there were no significant differences in weight regain; however, changes from baseline in % fat mass and lean mass were more favorable in ADF. Conclusions: ADF is a safe and tolerable approach to weight loss. ADF produced similar changes in weight, body composition, lipids, and Si at 8 weeks and did not appear to increase risk for weight regain 24 weeks after completing the intervention.
Article
Most animals alternate periods of feeding with periods of fasting often coinciding with sleep. Upon >24 hr of fasting, humans, rodents, and other mammals enter alternative metabolic phases, which rely less on glucose and more on ketone body-like carbon sources. Both intermittent and periodic fasting result in benefits ranging from the prevention to the enhanced treatment of diseases. Similarly, time-restricted feeding (TRF), in which food consumption is restricted to certain hours of the day, allows the daily fasting period to last >12 hr, thus imparting pleiotropic benefits. Understanding the mechanistic link between nutrients and the fasting benefits is leading to the identification of fasting-mimicking diets (FMDs) that achieve changes similar to those caused by fasting. Given the pleiotropic and sustained benefits of TRF and FMDs, both basic science and translational research are warranted to develop fasting-associated interventions into feasible, effective, and inexpensive treatments with the potential to improve healthspan.
Article
Although 5%–10% weight loss is routinely recommended for people with obesity, the precise effects of 5% and further weight loss on metabolic health are unclear. We conducted a randomized controlled trial that evaluated the effects of 5.1% ± 0.9% (n = 19), 10.8% ± 1.3% (n = 9), and 16.4% ± 2.1% (n = 9) weight loss and weight maintenance (n = 14) on metabolic outcomes. 5% weight loss improved adipose tissue, liver and muscle insulin sensitivity, and β cell function, without a concomitant change in systemic or subcutaneous adipose tissue markers of inflammation. Additional weight loss further improved β cell function and insulin sensitivity in muscle and caused stepwise changes in adipose tissue mass, intrahepatic triglyceride content, and adipose tissue expression of genes involved in cholesterol flux, lipid synthesis, extracellular matrix remodeling, and oxidative stress. These results demonstrate that moderate 5% weight loss improves metabolic function in multiple organs simultaneously, and progressive weight loss causes dose-dependent alterations in key adipose tissue biological pathways.